“oral”的搜索结果，显示 131-140 项，共有 4150 项

1. 强直阵挛性发作（癫痫大发作） - 症状与病因- 妙佑医疗国际

   Lamotrigine oral. Facts & Comparisons eAnswers. https://fco.factsandcomparisons.com. Accessed March 12, 2023. Wiggs KK, et al. Antiseizure medication use ...

2. 牙痛：急救 - 妙佑医疗国际

   Toothache and infection. Merck Manual Professional Version. https://www.merckmanuals.com/professional/dental-disorders/symptoms-of-dental-and-oral-disorders/ ...

3. 干槽症- 诊断与治疗- 妙佑医疗国际

   Chow O, et al. Alveolar osteitis: A review of current concepts. Journal of Oral and Maxillofacial Surgery. 2020; doi:10.1016/j.joms.2020.03.026. Ghosh A, et ...

4. 沙丁胺醇的副作用：我能否避开这些副作用？ - 妙佑医疗国际

   沙丁胺醇是一种短效支气管扩张剂类药物。这种药物通过松弛气道的平滑肌来缓解哮喘发作，通常用定量吸入气雾剂（ProAir HFA、Proventil HFA 等）给药。也可以用一种叫“雾化 ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg orally twice daily (BID), or critozinib, 250 mg orally BID. ... oral, target dose ...

6. 面部提升术- 医生与科室- 妙佑医疗国际

   In: Current Therapy in Oral and Maxillofacial Surgery. Philadelphia, Pa.: Saunders Elsevier; 2012. Nguyen H. Allscripts EPSi. Mayo Clinic. June 22, 2022.

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg orally twice daily (BID), or critozinib, 250 mg orally BID. ... oral, target dose ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg orally twice daily (BID), or critozinib, 250 mg orally BID. ... oral, target dose ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg orally twice daily (BID), or critozinib, 250 mg orally BID. ... oral, target dose ...

10. 软组织肉瘤 - 医生与科室- 妙佑医疗国际

    Kevin Arce, M.D., D.M.D.. Oral and Maxillofacial Surgeon. Rochester, MN. 擅长领域：. Cancer rehabilitation, Cancer treatment, Skin biopsy, Trauma care ...